Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1988 May;81(5):1348–1354. doi: 10.1172/JCI113462

Clearance and early hydrolysis of atrial natriuretic factor in vivo. Structural analysis of cleavage sites and design of an analogue that inhibits hormone cleavage.

C L Condra 1, E A Leidy 1, P Bunting 1, C D Colton 1, R F Nutt 1, M Rosenblatt 1, J W Jacobs 1
PMCID: PMC442563  PMID: 2966813

Abstract

This study examines the clearance and early hydrolysis of atrial natriuretic factor (ANF) in vivo. Radiolabeled ANF was cleared from the circulation of the rat with biphasic kinetics; the majority (90%) of ANF cleared with a t1/2 of 15 s, the remaining peptide was cleared with a t1/2 of 5 min. Microsequence analysis of ANF peptides recovered from the circulation of rats revealed five major degradation products of the intact hormone. The first cleavage occurred between amino acids 12 and 13 of the hormone and would inactivate ANF. Over time, additional fragments of the hormone were generated, including fragments of 6, 7, 21, and 24 amino acids in length. Whole body radioautography of rats injected with [123I]-ANF revealed the kidney as a predominant organ involved in clearance of ANF. Subsequent amino acid sequence analyses of radiolabeled ANF exposed to the kidney in vivo indicated that this organ generated four of the five major hydrolysis products observed in circulation, namely, the 6, 7, 16, and 21 amino acid fragments of the hormone. In an attempt to stabilize ANF in vivo, a synthetic analogue of the hormone was prepared that contained the amino acid analogue, aminoisobutyric acid, substituted at position 13. This analogue completely abolished the in vivo cleavage of ANF at this site. These studies demonstrate the usefulness of a protein chemistry approach in characterizing hormone metabolism in vivo and designing analogues with enhanced in vivo stability to cleavage.

Full text

PDF
1348

Images in this article

1351Image
on p.1351
1351Image
on p.1351
1351Image
on p.1351
1351Image
on p.1351

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson J. V., Bloom S. R. Atrial natriuretic peptide: what is the excitement all about? J Endocrinol. 1986 Jul;110(1):7–17. doi: 10.1677/joe.0.1100007. [DOI] [PubMed] [Google Scholar]
  2. Bianchi C., Anand-Srivastava M. B., De Léan A., Gutkowska J., Forthomme D., Genest J., Cantin M. Localization and characterization of specific receptors for atrial natriuretic factor in the ciliary processes of the eye. Curr Eye Res. 1986 Apr;5(4):283–293. doi: 10.3109/02713688609020054. [DOI] [PubMed] [Google Scholar]
  3. Bianchi C., Gutkowska J., Thibault G., Garcia R., Genest J., Cantin M. Radioautographic localization of 125I-atrial natriuretic factor (ANF) in rat tissues. Histochemistry. 1985;82(5):441–452. doi: 10.1007/BF02450479. [DOI] [PubMed] [Google Scholar]
  4. Espiner E. A., Nicholls M. G., Yandle T. G., Crozier I. G., Cuneo R. C., McCormick D., Ikram H. Studies on the secretion, metabolism and action of atrial natriuretic peptide in man. J Hypertens Suppl. 1986 Jun;4(2):S85–S91. [PubMed] [Google Scholar]
  5. Flynn T. G., Davies P. L. The biochemistry and molecular biology of atrial natriuretic factor. Biochem J. 1985 Dec 1;232(2):313–321. doi: 10.1042/bj2320313. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Flynn T. G., de Bold M. L., de Bold A. J. The amino acid sequence of an atrial peptide with potent diuretic and natriuretic properties. Biochem Biophys Res Commun. 1983 Dec 28;117(3):859–865. doi: 10.1016/0006-291x(83)91675-3. [DOI] [PubMed] [Google Scholar]
  7. Inagami T., Misono K. S., Grammer R. T., Fukumi H., Maki M., Tanaka I., McKenzie J. C., Takayanagi R., Pandey K. N., Parmentier M. Biochemical studies of rat atrial natriuretic factor. Clin Exp Hypertens A. 1985;7(5-6):851–867. doi: 10.3109/10641968509077232. [DOI] [PubMed] [Google Scholar]
  8. Katsube N., Schwartz D., Needleman P. Atriopeptin turnover: quantitative relationship between in vivo changes in plasma levels and atrial content. J Pharmacol Exp Ther. 1986 Nov;239(2):474–479. [PubMed] [Google Scholar]
  9. Leitman D. C., Andresen J. W., Kuno T., Kamisaki Y., Chang J. K., Murad F. Identification of multiple binding sites for atrial natriuretic factor by affinity cross-linking in cultured endothelial cells. J Biol Chem. 1986 Sep 5;261(25):11650–11655. [PubMed] [Google Scholar]
  10. Misono K. S., Grammer R. T., Fukumi H., Inagami T. Rat atrial natriuretic factor: isolation, structure and biological activities of four major peptides. Biochem Biophys Res Commun. 1984 Sep 17;123(2):444–451. doi: 10.1016/0006-291x(84)90250-x. [DOI] [PubMed] [Google Scholar]
  11. Murthy K. K., Thibault G., Garcia R., Gutkowska J., Genest J., Cantin M. Degradation of atrial natriuretic factor in the rat. Biochem J. 1986 Dec 1;240(2):461–469. doi: 10.1042/bj2400461. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Murthy K. K., Thibault G., Schiffrin E. L., Garcia R., Chartier L., Gutkowska J., Genest J., Cantin M. Disappearance of atrial natriuretic factor from circulation in the rat. Peptides. 1986 Mar-Apr;7(2):241–246. doi: 10.1016/0196-9781(86)90220-2. [DOI] [PubMed] [Google Scholar]
  13. Napier M. A., Vandlen R. L., Albers-Schönberg G., Nutt R. F., Brady S., Lyle T., Winquist R., Faison E. P., Heinel L. A., Blaine E. H. Specific membrane receptors for atrial natriuretic factor in renal and vascular tissues. Proc Natl Acad Sci U S A. 1984 Oct;81(19):5946–5950. doi: 10.1073/pnas.81.19.5946. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Segre G. V., Niall H. D., Sauer R. T., Potts J. T., Jr Edman degradation of radioiodinated parathyroid hormone: application to sequence analysis and hormone metabolism in vivo. Biochemistry. 1977 May 31;16(11):2417–2427. doi: 10.1021/bi00630a017. [DOI] [PubMed] [Google Scholar]
  15. Stephenson S. L., Kenny A. J. The hydrolysis of alpha-human atrial natriuretic peptide by pig kidney microvillar membranes is initiated by endopeptidase-24.11. Biochem J. 1987 Apr 1;243(1):183–187. doi: 10.1042/bj2430183. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Sylvestre D. L., Zisfein J. B., Graham R. M., Homcy C. J. Serum-mediated enhancement of ANF accumulation in the culture medium of cardiac atriocytes. Biochem Biophys Res Commun. 1986 Oct 15;140(1):151–159. doi: 10.1016/0006-291x(86)91070-3. [DOI] [PubMed] [Google Scholar]
  17. Thibault G., Garcia R., Gutkowska J., Genest J., Cantin M. Atrial natriuretic factor. A newly discovered hormone with significant clinical implications. Drugs. 1986 May;31(5):369–375. doi: 10.2165/00003495-198631050-00001. [DOI] [PubMed] [Google Scholar]
  18. Thibault G., Garcia R., Gutkowska J., Lazure C., Seidah N. G., Chrétien M., Genest J., Cantin M. Identification of the released form of atrial natriuretic factor by the perfused rat heart. Proc Soc Exp Biol Med. 1986 May;182(1):137–141. doi: 10.3181/00379727-182-1-rc3. [DOI] [PubMed] [Google Scholar]
  19. Veress A. T., Chong C. K., Sonnenberg H. Inactivation of atrial natriuretic factor in blood. Can J Physiol Pharmacol. 1985 Dec;63(12):1615–1617. doi: 10.1139/y85-267. [DOI] [PubMed] [Google Scholar]
  20. Vlasuk G. P., Babilon R. W., Nutt R. F., Ciccarone T. M., Winquist R. J. The actions of atrial natriuretic factor on the vascular wall. Can J Physiol Pharmacol. 1987 Aug;65(8):1684–1689. doi: 10.1139/y87-264. [DOI] [PubMed] [Google Scholar]
  21. Yandle T. G., Richards A. M., Nicholls M. G., Cuneo R., Espiner E. A., Livesey J. H. Metabolic clearance rate and plasma half life of alpha-human atrial natriuretic peptide in man. Life Sci. 1986 May 19;38(20):1827–1833. doi: 10.1016/0024-3205(86)90137-2. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES